A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans-Reference-Cited by-同舟云学术

A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans

Published:2014-07-08 Issue:9 Volume:42 Page:1456-1465
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Mizuno-Yasuhira Akiko,Nakai Yasuhiro,Gunji Emi,Uchida Saeko,Takahashi Teisuke,Kinoshita Kohnosuke,Jingu Shigeji,Sakai Soichi,Samukawa Yoshishige,Yamaguchi Jun-ichi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference28 articles.

1. Predicting the impact of physiological and biochemical processes on oral drug bioavailability

2. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

3. Refining the In Vitro and In Vivo Critical Parameters for P-Glycoprotein, [I]/IC50 and [I2]/IC50, That Allow for the Exclusion of Drug Candidates from Clinical Digoxin Interaction Studies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using a Mathematical Modeling To Simulate Pharmacokinetics and Urinary Glucose Excretion of Luseogliflozin and Explore the Role of SGLT1/2 in Renal Glucose Reabsorption;ACS Omega;2022-12-15

2. Intestinal Absorption and Tissue Distribution of Aza-Sugars from Mulberry Leaves and Evaluation of Their Transport by Sugar Transporters;Journal of Agricultural and Food Chemistry;2020-05-25

3. Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, in humans;Xenobiotica;2016-06-27

4. In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor;Xenobiotica;2016-06-20

5. Preclinical metabolism and disposition of luseogliflozin, a novel antihyperglycemic agent;Xenobiotica;2015-07-06